Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,898 | 17,329 | 14,473 | 9,935 | -85,480 |
| Depreciation Amortization | 1,588 | 1,088 | 643 | 415 | 1,114 |
| Income taxes - deferred | -1,002 | -410 | -410 | -313 | -1,160 |
| Accounts receivable | -5,257 | -4,111 | -3,361 | -31 | 285 |
| Accounts payable and accrued liabilities | -245 | -55 | -83 | -23 | 192 |
| Other Working Capital | -15,688 | -12,067 | -10,142 | -2,757 | 7,458 |
| Other Operating Activity | -935 | -2,657 | -3,729 | -4,342 | 103,483 |
| Operating Cash Flow | $-3,641 | $-883 | $-2,609 | $2,884 | $25,892 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,686 | -1,686 | N/A | N/A | -1,000 |
| PPE Investments | -1,914 | -2,117 | -1,419 | -181 | -7,853 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -124 |
| Purchase Of Investment | -15,471 | -14,074 | -14,074 | -7,039 | -15,735 |
| Purchase Sale Intangibles | -813 | -3 | N/A | N/A | -69 |
| Other Investing Activity | -813 | -3 | 0 | 0 | 4,952 |
| Investing Cash Flow | $-19,884 | $-17,880 | $-15,493 | $-7,220 | $-19,760 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,638 | 1,307 | 933 | 658 | N/A |
| Other Financing Activity | -536 | -169 | -119 | 0 | 2,500 |
| Financing Cash Flow | $2,102 | $1,138 | $814 | $658 | $2,500 |
| Exchange Rate Effect | -273 | -18 | -124 | -46 | -298 |
| Beginning Cash Position | 33,509 | 33,509 | 33,509 | 33,509 | 25,175 |
| End Cash Position | 11,813 | 15,866 | 16,097 | 29,785 | 33,509 |
| Net Cash Flow | $-21,696 | $-17,643 | $-17,412 | $-3,724 | $8,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,641 | -883 | -2,609 | 2,884 | 25,892 |
| Capital Expenditure | -2,315 | -2,380 | -1,687 | -231 | -8,517 |
| Free Cash Flow | -5,956 | -3,263 | -4,296 | 2,653 | 17,375 |